Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 3511-3520 of 11519

Edit search filters
  1. A Study Evaluating Tolerability and Efficacy of Navitoclax in Combination With Ruxolitinib in Subjects With Myelofibrosis

    Jacksonville, FL

  2. A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia with and without Red Blood Cell-Transfusion Dependence

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. Social Media Intervention to Promote Smoking Treatment Utilization and Cessation among Alaska Native Smokers

    Rochester, MN

  4. Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil

    Jacksonville, FL

  5. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission

    Rochester, MN

  7. A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

    Jacksonville, FL, Rochester, MN

  8. Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. Ketamine for Depression and Suicide Risk

  10. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors

    Rochester, MN, Jacksonville, FL, Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer